metoprolol has been researched along with Asystole in 32 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"During the initial hospitalization, ventricular fibrillation (VF) developed in 6 metoprolol-treated patients (0." | 7.67 | Göteborg Metoprolol Trial: effects on arrhythmias. ( Edvardsson, N; Herlitz, J; Hjalmarson, A; Holmberg, S; Rydén, L; Swedberg, K; Waagstein, F; Waldenström, A, 1984) |
" In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, randomized trial, was initiated to compare metoprolol, amiodarone, propafenone, and ICD implantation in patients surviving sudden cardiac death due to documented ventricular tachycardia and/or ventricular fibrillation." | 5.07 | Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. ( Cappato, R; Kuck, KH; Rüppel, R; Schneider, MA; Siebels, J, 1993) |
"We document a pediatric case report of death due to a mixed drug overdose of metoprolol and propafenone, along with data regarding serum metoprolol, alfa-hydroxymetoprolol, and propafenone levels." | 3.85 | Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone - A first pediatric case report. ( Grundmann, M; Handlos, P; Kacirova, I; Kolek, M; Urinovska, R; Vyskocilova-Hrudikova, E, 2017) |
"During the initial hospitalization, ventricular fibrillation (VF) developed in 6 metoprolol-treated patients (0." | 3.67 | Göteborg Metoprolol Trial: effects on arrhythmias. ( Edvardsson, N; Herlitz, J; Hjalmarson, A; Holmberg, S; Rydén, L; Swedberg, K; Waagstein, F; Waldenström, A, 1984) |
"During long-term follow-up of cardiac arrest survivors, therapy with an ICD is associated with a 23% (nonsignificant) reduction of all-cause mortality rates when compared with treatment with amiodarone/metoprolol." | 2.69 | Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). ( Cappato, R; Kuck, KH; Rüppel, R; Siebels, J, 2000) |
"In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, multicenter, randomized controlled study, was started in survivors of sudden cardiac death resulting from documented ventricular tachyarrhythmias." | 2.67 | Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). ( Kuck, KH; Siebels, J, 1994) |
"Despite these therapies, he developed cardiac arrest for 55 minutes, requiring epinephrine (5 mg IV) and vasopressin (40 U IV) with multiple episodes of return of spontaneous circulation." | 1.42 | Successful treatment of metoprolol-induced cardiac arrest with high-dose insulin, lipid emulsion, and ECMO. ( Escajeda, JT; Katz, KD; Rittenberger, JC, 2015) |
"Metoprolol is a moderately lipophilic β-blocker that in overdose causes direct myocardial depression leading to bradycardia, hypotension, and the potential for cardiovascular collapse." | 1.42 | Successful treatment of a massive metoprolol overdose using intravenous lipid emulsion and hyperinsulinemia/euglycemia therapy. ( Barton, CA; Beauchamp, G; Hendrickson, R; Johnson, NB; Mah, ND, 2015) |
"MI+metoprolol group had a lower ROSC rate than MI group in the medium dose subgroup, and a higher ROSC rate than MI group in the high dose subgroup." | 1.39 | β-Receptor blocker influences return of spontaneous circulation and chemical examination in rats during cardiopulmonary resuscitation. ( Chen, EX; Gao, YX; Li, LJ; Li, P; Liu, J; Pen, Z; Ren, YX; Zhao, XJ, 2013) |
"Patients in cardiac arrest are often taking medications affecting adrenergic activity such as the beta blocker metoprolol and the combined alpha and beta blocker, labetalol." | 1.38 | Beta-blockade causes a reduction in the frequency spectrum of VF but improves resuscitation outcome: A potential limitation of quantitative waveform measures. ( Niemann, J; Rosborough, JP; Shah, AP; Sherman, L; Youngquist, ST, 2012) |
" The latter, however, was taking antiarrhythmic drugs at a dosage less than that proved to be effective during electropharmacological testing." | 1.27 | [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. ( Delise, P; Di Pede, F; Piccolo, E; Raviele, A, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (9.38) | 18.7374 |
1990's | 12 (37.50) | 18.2507 |
2000's | 7 (21.88) | 29.6817 |
2010's | 9 (28.13) | 24.3611 |
2020's | 1 (3.13) | 2.80 |
Authors | Studies |
---|---|
Juusela, A | 1 |
Nazir, M | 1 |
Gimovsky, M | 1 |
Kacirova, I | 1 |
Grundmann, M | 1 |
Kolek, M | 1 |
Vyskocilova-Hrudikova, E | 1 |
Urinovska, R | 1 |
Handlos, P | 1 |
Zhao, XJ | 1 |
Pen, Z | 1 |
Li, P | 1 |
Chen, EX | 1 |
Liu, J | 1 |
Gao, YX | 1 |
Ren, YX | 1 |
Li, LJ | 1 |
Abu-Zeitone, A | 1 |
Peterson, DR | 1 |
Polonsky, B | 1 |
McNitt, S | 1 |
Moss, AJ | 1 |
Escajeda, JT | 1 |
Katz, KD | 1 |
Rittenberger, JC | 1 |
Barton, CA | 1 |
Johnson, NB | 1 |
Mah, ND | 1 |
Beauchamp, G | 1 |
Hendrickson, R | 1 |
Maskell, KF | 1 |
Ferguson, NM | 1 |
Bain, J | 1 |
Wills, BK | 1 |
Smith, BB | 1 |
Nickels, AS | 1 |
Sviggum, HP | 1 |
Rolfo, F | 1 |
Bobbio, M | 1 |
Angeli, F | 1 |
Cavallini, C | 1 |
Alonso-Coello, P | 1 |
Alvarez, C | 1 |
Cruz, P | 1 |
Torán, L | 1 |
De Nadal, M | 1 |
Martínez, M | 1 |
Paniagua, P | 1 |
Mases, A | 1 |
Urrutia, G | 1 |
Peacock, A | 1 |
Ross, K | 1 |
Sherman, L | 1 |
Niemann, J | 1 |
Youngquist, ST | 1 |
Shah, AP | 1 |
Rosborough, JP | 1 |
Cappato, R | 4 |
Boczor, S | 1 |
Kuck, KH | 5 |
Hohnloser, SH | 1 |
Dorian, P | 1 |
Roberts, R | 1 |
Gent, M | 1 |
Israel, CW | 1 |
Fain, E | 1 |
Champagne, J | 1 |
Connolly, SJ | 1 |
Devereaux, PJ | 1 |
Yang, H | 1 |
Guyatt, GH | 1 |
Leslie, K | 1 |
Villar, JC | 1 |
Monteri, VM | 1 |
Choi, P | 1 |
Giles, JW | 1 |
Yusuf, S | 1 |
Jacobs, A | 1 |
Knight, BP | 1 |
McDonald, KT | 1 |
Burke, MC | 1 |
Raviele, A | 1 |
Di Pede, F | 1 |
Delise, P | 1 |
Piccolo, E | 1 |
Herlitz, J | 1 |
Edvardsson, N | 1 |
Holmberg, S | 1 |
Rydén, L | 1 |
Waagstein, F | 1 |
Waldenström, A | 1 |
Swedberg, K | 1 |
Hjalmarson, A | 1 |
Siebels, J | 4 |
Rüppel, R | 3 |
Schneider, MA | 2 |
Viskin, S | 1 |
Belhassen, B | 1 |
Roach, PJ | 1 |
Magee, MA | 1 |
Freedman, SB | 1 |
Sra, JS | 1 |
Jazayeri, MR | 1 |
Avitall, B | 1 |
Dhala, A | 1 |
Deshpande, S | 1 |
Blanck, Z | 1 |
Akhtar, M | 1 |
Pentousis, D | 1 |
Cooper, JP | 1 |
Cobbe, SM | 1 |
Deal, BJ | 1 |
Strieper, M | 1 |
Scagliotti, D | 1 |
Hulse, E | 1 |
Auld, D | 1 |
Campbell, R | 1 |
Strasburger, JF | 1 |
Benson, DW | 1 |
Calle, PA | 1 |
Buylaert, W | 1 |
Dangovian, MI | 1 |
Jarandilla, R | 1 |
Frumin, H | 1 |
Kinney, RO | 1 |
Tai, YT | 1 |
Lo, CW | 1 |
Chow, WH | 1 |
Cheng, CH | 1 |
Stafford, WJ | 1 |
Trohman, RG | 1 |
Bilsker, M | 1 |
Zaman, L | 1 |
Castellanos, A | 1 |
Myerburg, RJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
[NCT00257959] | Phase 4 | 400 participants | Interventional | 2001-01-31 | Completed | ||
Perioperative Ischemic Evaluation Study (POISE) Trial[NCT00182039] | Phase 3 | 8,351 participants (Actual) | Interventional | 2002-10-31 | Terminated (stopped due to Please see detailed description for reason why study was terminated.) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for metoprolol and Asystole
Article | Year |
---|---|
[The POISE study].
Topics: Adrenergic beta-Antagonists; Bradycardia; Delayed-Action Preparations; Heart Arrest; Humans; Hyperte | 2008 |
6 trials available for metoprolol and Asystole
Article | Year |
---|---|
Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrophysiologic Techniques, Card | 2004 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1993 |
Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Hea | 1994 |
Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1993 |
Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Heart Arrest; Humans; | 2000 |
25 other studies available for metoprolol and Asystole
Article | Year |
---|---|
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Blood Gas Analysi | 2020 |
Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone - A first pediatric case report.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Anti-Arrhythmia Agents; Brain Edema; Cerebral He | 2017 |
β-Receptor blocker influences return of spontaneous circulation and chemical examination in rats during cardiopulmonary resuscitation.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cardiopulmonary Resuscitation; Combined Modality Th | 2013 |
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Ca | 2014 |
Successful treatment of metoprolol-induced cardiac arrest with high-dose insulin, lipid emulsion, and ECMO.
Topics: Adrenergic beta-1 Receptor Antagonists; Drug Overdose; Extracorporeal Membrane Oxygenation; Fat Emul | 2015 |
Successful treatment of a massive metoprolol overdose using intravenous lipid emulsion and hyperinsulinemia/euglycemia therapy.
Topics: Adrenergic beta-1 Receptor Antagonists; Drug Overdose; Fat Emulsions, Intravenous; Heart Arrest; Hum | 2015 |
Survival After Cardiac Arrest: ECMO Rescue Therapy After Amlodipine and Metoprolol Overdose.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Amlodipine; Calcium Channel Blockers; Drug Overd | 2017 |
A rare combination of undiagnosed hypertrophic cardiomyopathy revealed by intraoperative anaphylaxis resulting in acute left ventricular outflow obstruction and cardiac arrest.
Topics: Aged; Anaphylaxis; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Cardiomyopathy, Hypertrophic; Echo | 2016 |
[Beta-blockers in patients undergoing noncardiac surgery: implications of the POISE study].
Topics: Adrenergic beta-Antagonists; Bradycardia; Contraindications; Female; Forecasting; Heart; Heart Arres | 2009 |
Pulmonary hypertension: a contraindication to the use of {beta}-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Contraindications; Female; Heart Arrest; Humans; Hypertension, Pulmonar | 2010 |
Beta-blockade causes a reduction in the frequency spectrum of VF but improves resuscitation outcome: A potential limitation of quantitative waveform measures.
Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Confidence Intervals; Disease M | 2012 |
Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
Topics: Adrenergic beta-Antagonists; Aged; Cardiovascular Diseases; Delayed-Action Preparations; Digestive S | 2006 |
Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8).
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Combined Modality Therapy; Defibrillat | 2006 |
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography | 1984 |
Göteborg Metoprolol Trial: effects on arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Female; Heart Arre | 1984 |
Clinical problem-solving. When you only live twice.
Topics: Adult; Death, Sudden, Cardiac; Defibrillators, Implantable; Diagnosis, Differential; Exercise Test; | 1995 |
Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Bradycardia; Dipyridamole; Electrocardiography; Exercise Test | 1993 |
Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Topics: Adolescent; Adult; Aged; Bradycardia; Cardiac Pacing, Artificial; Disopyramide; Female; Follow-Up St | 1993 |
Prolonged asystole induced by head up tilt test. Report of four cases and brief review of the prognostic significance and medical management.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Disopyramide; Female; Heart | 1997 |
The medical therapy of cardioinhibitory syncope in pediatric patients.
Topics: Adrenergic Agonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Child; Cohort Studies; Disopy | 1997 |
When an AED meets an ICD... Automated external defibrillator. Implantable cardioverter defibrillator.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cardiopulmonary Resuscitation; Clinical Prot | 1998 |
Prolonged asystole during head-up tilt table testing after beta blockade.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Female; Heart Arrest; Humans; Hypotension, Orthosta | 1992 |
Cardiac arrest in an on-call intern.
Topics: Adult; Heart Arrest; Humans; Hypotension, Orthostatic; Male; Metoprolol; Syncope | 1991 |
Successful resuscitation and survival following massive overdose of metoprolol.
Topics: Adult; Drug Overdose; Female; Glucagon; Heart Arrest; Humans; Metoprolol; Pregnancy; Pregnancy Compl | 1990 |
Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy.
Topics: Adolescent; Atrial Fibrillation; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy | 1986 |